Neoral Solution
Product Images NDC 0078-0274

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neoral (NDC 0078-0274). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Neoral 01

Neoral 01
NEORAL Soft Gelatin Capsules - modified cyclosporine capsules used for immunosuppressive agents for organ transplantation, psoriasis, and rheumatoid arthritis. The medication is produced by Novartis and comes in a package of 30 capsules. The provided information also includes the NDC number.*
FDA Label Image

Chemical Structure Of Cyclosporine (Neoral 02)

Chemical Structure Of Cyclosporine (Neoral 02)
FDA Label Image

Study 302 Enrolled 299 Patients With Severe Active Ra, 99% Of Whom Were Unresponsive Or Intolerant To At Least One Prior Major Ra Drug. Patients Were Randomized To 1 Of 2 Treatment Groups (1) Neoral® And (2) Cyclosporine, Both Of Which Were Started At 2.5 mg/kg/day And Increased After 4 Weeks For Inefficacy In Increments Of 0.5 mg/kg/day To A Maximum Of 5 mg/kg/day And Decreased At Any Time For Toxicity. Treatment Duration Was 24 Weeks. The Mean Cyclosporine Dose At The Last Visit Was 2.91 mg/kg/day (range: 0.72-5.17) For Neoral® And 3.27 mg/kg/day (range: 0.73 5.68) For Cyclosporine. (Neoral 03)

Study 302 Enrolled 299 Patients With Severe Active Ra, 99% Of Whom Were Unresponsive Or Intolerant To At Least One Prior Major Ra Drug. Patients Were Randomized To 1 Of 2 Treatment Groups (1) Neoral® And (2) Cyclosporine, Both Of Which Were Started At 2.5 mg/kg/day And Increased After 4 Weeks For Inefficacy In Increments Of 0.5 mg/kg/day To A Maximum Of 5 mg/kg/day And Decreased At Any Time For Toxicity. Treatment Duration Was 24 Weeks. The Mean Cyclosporine Dose At The Last Visit Was 2.91 mg/kg/day (range: 0.72-5.17) For Neoral® And 3.27 mg/kg/day (range: 0.73 5.68) For Cyclosporine. (Neoral 03)
FDA Label Image

Principal Display Panel – Package Label – 25 mg Soft Gelatin Capsules (Neoral 04)

Principal Display Panel – Package Label – 25 mg Soft Gelatin Capsules (Neoral 04)
NEORAL soft gelatin capsules are a medication containing cyclosporine used to prevent rejection of transplant, treat autoimmune diseases, and treat other conditions. The provided text also includes some identification numbers but is otherwise not readable.*
FDA Label Image

Principal Display Panel – Package Label – 100 mg Soft Gelatin Capsules (Neoral 05)

Principal Display Panel – Package Label – 100 mg Soft Gelatin Capsules (Neoral 05)
This text seems to be a mix of various pieces of information about a medical product, specifically the NEORAL Oral Solution by Novartis. It includes a warning about not using this solution interchangeably with other similar products without physician supervision. The text also describes the precise dosing capabilities of the solution, how it should be used, and its accurate measurement for accurate dosing. It also includes information about the manufacturer and the strength of the solution.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.